Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q2 2025 (June 30)12holders +1
1new positions
0sold out
$26.06avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Sterling Capital Management LLC ($1.9M), Confluence Investment Management LLC ($1.0M) and Rhumbline Advisers ($732K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $444 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 3,760 shares bought and 1,396 shares sold, net +2,364 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Sterling Capital Management LLC | 0.03% | Add +1.9% | 73,347 | $1.9M |
| Confluence Investment Management LLC | 0.01% | Add +1.6% | 39,539 | $1.0M |
| Rhumbline Advisers | 0.00% | Add +2.3% | 28,068 | $732K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -7.0% | 12,465 | $325K |
| GAMMA Investing LLC | 0.02% | Add +11.2% | 10,983 | $286K |
| Riverbridge Partners LLC | 0.00% | Reduce -0.9% | 10,773 | $281K |
| Brooklyn Investment Group | 0.01% | Reduce -3.1% | 1,459 | $38K |
| Hantz Financial Services, Inc. | 0.00% | Reduce -22.9% | 398 | $10K |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0.00% | No change | 256 | $7K |
| Accent Capital Management, LLC | 0.00% | Reduce -50.0% | 200 | $5K |
| Richardson Financial Services Inc. | 0.00% | No change | 28 | $730 |
| Salomon & Ludwin, LLC | 0.00% | New | 18 | $444 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.